CGCLF yields 4.78% · PFE yields 6.13%● Live data
📍 CGCLF pulled ahead of the other in Year 1
Combined, CGCLF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CGCLF + PFE for your $10,000?
Central Glass Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of flat glass and chemical products for customers in Japan, North America, Europe, Asia, and internationally. The company operates in two segments, Glass Business and Chemicals Business. It offers architectural glass products, including soundproof, laminated, security, tempered, fire protection, high transparent, and special construction, as well as eco-glass and anti-fog mirrors; automotive glass products comprising laminated, tempered, UV cut, privacy, IR cut, water repellent, acoustic, laminated side, panoramic roof, de-icer, and defogging glasses, as well as glass antenna and module windows; and glass fiber and glass wool products. The company also provides chemical products; fine chemicals, such as aromatic products, aliphatic compounds, chiral compounds, trifluoromethanesulfonic acid and derivatives, aromatic monomers, aliphatic monomers, fluorine resins, and reagents; fertilizers; and microbial control agents and materials. The company was formerly known as Ube Soda Industry Co., Ltd. and changed its name to Central Glass Co., Ltd. in 1963. Central Glass Co., Ltd. was incorporated in 1936 and is headquartered in Tokyo, Japan.
Full CGCLF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.